Most recently, Indapta Therapeutics raised $50.8M in its Later Stage VC (Sep 2025).
- ·The complete investor list: 11 names
- ·Watch Indapta Therapeutics: the Monday email on marks, rounds and moves
Indapta Therapeutics round by round
4 roundsHow much has Indapta Therapeutics raised?
Indapta Therapeutics has raised $162 million across 4 recorded rounds since 2022. The largest was an $80 million Series A in May 2023; the most recent was a $50.8 million later-stage round in Sep 2025.
Indapta Therapeutics has filed 1 Form D with the SEC, most recently in Feb 2022 ($33.6 million sold to 37 investors).
Indapta Therapeutics investors
11 investors are on record for Indapta Therapeutics, including RA Capital Management, Cancer Prevention and Research Institute of Texas, Leaps by Bayer and Leerink Partners. The later-stage round in Sep 2025 drew 46 investors.
11 investors have backed Indapta Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Indapta Therapeutics
- How much has Indapta Therapeutics raised?
- Indapta Therapeutics has raised $162.3M in total across 4 recorded funding rounds.
- When was Indapta Therapeutics's last funding round?
- Indapta Therapeutics's most recent recorded round was Later Stage VC in Sep 2025, raising $50.8M.